Grey Fox Wealth Advisors, LLC

SEC CIK: 0001965362
Latest filing: Jul 17, 2026

SEC filings (opens in a new tab)

AVXL holding history

Anavex Life Sciences Corp. in every 13F filed by Grey Fox Wealth Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVXL overview All 13F holders of AVXL Full Q2 2026 holdings

Shares (Q1 2023): 0; Sold out in Q1 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 1; Since Q4 2022

Holdings of AVXL by Grey Fox Wealth Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2023	0	$0	0.0%	−300−100.0%	Sold out	Holders
Q4 2022	300	$2.78K	<0.1%	–	No prior filing	Holders